secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001753926-23-001558
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella believes it meets Nasdaq minimum equity rule after $2M private placement
--------------------------------------------------------------------------------

- Private placement closed Oct 25, 2023; gross proceeds $2.0M, net ~$1.7M.
- Stockholders' equity as-adjusted: ~$3.9M (Sep 30, 2023) and ~$3.8M (Oct 31, 2023), above $2.5M minimum.
- Nasdaq will continue to monitor ongoing compliance; no assurance of future compliance.
- Previously disclosed Nasdaq delinquency notice on Nov 21, 2023 for minimum equity rule.
- Pre-funded warrants issued at $1.519/unit; exercise $0.001 per share; common warrants $1.40, 3-year term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001558/0001753926-23-001558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001558/g083874_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer